Limay Biosciences, a biotech startup focused on making molecular testing more accessible, has secured $600K in a new seed funding round. The company is developing innovative technologies aimed at decentralizing and democratizing access to critical health and food quality insights.
This seed capital will support Limay Biosciences' efforts to enable real-time decision-making regarding food quality and personal health, ultimately moving molecular diagnostics out of centralized labs and into more accessible settings for broader impact.
